Article

Unveiling the Uncommon: Targeting Rare MET Fusions in NSCLC: A Comprehensive Review

2025-03-06

Abstract excerpt

<h4>Background: </h4> /Objectives: Advancements in molecular diagnostics and targeted therapies have significantly transformed the management of non-small cell lung cancer (NSCLC). Rare MET rearrangements, including novel fusions such as HLA-DRB1-MET and HLA-DQB2-MET, represent actionable genetic alterations with critical therapeutic implications. This review synthesizes findings from multiple case reports to high...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8eea3787-291a-5f22-ae2a-21e76a801a4a
DOI: 10.20944/preprints202503.0423.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Unveiling the Uncommon: Targeting Rare MET Fusions in NSCLC: A Comprehensive ReviewDOI 10.20944/preprints202503.0423.v1Read

Molecular characterization of MET fusions from a large real-world Chinese population: A multicenter study.Semantic proximity Read

Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer.Semantic proximity Read

Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.Semantic proximity Read

Analysis of MET kinase domain rearrangement in NSCLC.Semantic proximity Read

MET fusions are targetable genomic variants in the treatment of advanced malignancies.Semantic proximity Read

MET alterations in NSCLC-Current Perspectives and Future Challenges.Semantic proximity Read

MET alterations and their impact on the future of non-small cell lung cancer (NSCLC) targeted therapies.Semantic proximity Read

MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.Semantic proximity Read

Tepotinib Efficacy in a Patient with Non-Small Cell Lung Cancer with Brain Metastasis Harboring an HLA-DRB1-MET Gene FusionSemantic proximity Read

Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alterationSemantic proximity Read

Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted TherapySemantic proximity Read

MET-dependent solid tumours - molecular diagnosis and targeted therapy.Semantic proximity Read